Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.

In the United States, prescriptions for weight-loss drugs for teens have increased 600 per cent, according to one study. But ...

Prescription drug market expands rapidly due to AI in pharma, rising diseases, and global access to advanced therapies. The prescription drugs market will grow from $1,240.33B in 2024 to $2,151.63B by ...

More American teenagers now use the weight-loss drug Wegovy, as doctors and families grow more comfortable with the treatment ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

Use of the weight-loss drug is rising among adolescents, but questions remain over long-term safety, access, and ...

Medicare Part D plans and some Part C plans may cover Trulicity (dulaglutide) for diabetes, but the exact coverage depends on the plan. Such plans will only cover this drug for weight loss in ...

Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...

And it’s never a bad time to re-read some of the team’s excellent, award-winning coverage on the company: Last week, key ...

Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo Nordisk, after negotiating a price cut with the company, along with Novo ...

While employers aren’t yet reimbursing weight loss drugs en masse, significantly reduced net costs could affect their future ...

Court filings give insight into why shooting suspect Louis Mangione might have targeted the UnitedHealthcare executive: "It checks every box." In other news: Hospital construction trends include AI; ...